We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$832M
AUM Growth
+$16M
Cap. Flow
-$29.5M
Cap. Flow %
-3.54%
Top 10 Hldgs %
27.57%
Holding
272
New
12
Increased
46
Reduced
130
Closed
9

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$11M
2
V icon
Visa
V
+$4.52M
3
MSFT icon
Microsoft
MSFT
+$4.28M
4
HUBB icon
Hubbell
HUBB
+$4.16M
5
CRM icon
Salesforce
CRM
+$2.77M

Sector Composition

Rank Sector Weight
1 Healthcare 19.83%
2 Industrials 15.05%
3 Energy 13.45%
4 Technology 12.5%
5 Financials 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
26
McDonald's
MCD
$196B
$8.77M 1.05%
74,184
PCP
27
DELISTED
PRECISION CASTPARTS CORP
PCP
$8.41M 1.01%
36,268
-9,540
-21% -$2.21M
MSFT icon
28
Microsoft
MSFT
$3.74T
$8.26M 0.99%
148,871
+81,280
+120% +$4.28M
SPY icon
29
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$8.18M 0.98%
40,131
+1,731
+5% +$355K
CVX icon
30
Chevron
CVX
$366B
$8.15M 0.98%
90,650
-12,033
-12% -$1.09M
JPM icon
31
JPMorgan Chase
JPM
$943B
$8.14M 0.98%
123,255
-1,400
-1% -$91.2K
PEP icon
32
PepsiCo
PEP
$189B
$7.71M 0.93%
77,211
-525
-0.7% -$52.4K
PNY
33
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$7.46M 0.9%
130,882
-29,421
-18% -$1.57M
NKE icon
34
Nike
NKE
$62.2B
$7.28M 0.88%
116,549
-783
-0.7% -$50.5K
BMY icon
35
Bristol-Myers Squibb
BMY
$132B
$7.16M 0.86%
104,140
+50
+0% +$3.3K
HD icon
36
Home Depot
HD
$354B
$6.93M 0.83%
52,377
-985
-2% -$125K
PFE icon
37
Pfizer
PFE
$151B
$6.75M 0.81%
220,292
+23,935
+12% +$753K
MDY icon
38
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
$6.44M 0.77%
25,348
-86
-0.3% -$22.4K
UPS icon
39
United Parcel Service
UPS
$88.5B
$6.43M 0.77%
66,811
-5,973
-8% -$610K
COST icon
40
Costco
COST
$420B
$6.38M 0.77%
39,482
+3,225
+9% +$510K
GBDC icon
41
Golub Capital BDC
GBDC
$3.39B
$6.33M 0.76%
388,378
-26,855
-6% -$441K
IBB icon
42
iShares Biotechnology ETF
IBB
$9.71B
$6.28M 0.75%
55,677
-4,155
-7% -$451K
WAB icon
43
Wabtec
WAB
$49.7B
$6.28M 0.75%
88,230
-1,345
-2% -$107K
J icon
44
Jacobs Solutions
J
$17B
$6.21M 0.75%
178,958
-14,075
-7% -$482K
UNP icon
45
Union Pacific
UNP
$175B
$6.05M 0.73%
77,347
-948
-1% -$81.3K
EMR icon
46
Emerson Electric
EMR
$88.3B
$5.92M 0.71%
123,760
-2,025
-2% -$96.4K
HSIC icon
47
Henry Schein
HSIC
$9.84B
$5.79M 0.7%
93,317
+637
+0.7% +$37.9K
BKU icon
48
Bankunited
BKU
$3.37B
$5.76M 0.69%
159,702
-7,686
-5% -$286K
HON icon
49
Honeywell
HON
$76.6B
$5.74M 0.69%
61,691
-501
-0.8% -$45.9K
PRGO icon
50
Perrigo
PRGO
$1.77B
$5.69M 0.68%
39,311
-19,014
-33% -$2.92M

Similar funds

Neville Rodie & Shaw's Q4 2015 Portfolio in Review

As of Q4 2015, Neville Rodie & Shaw held 272 positions worth $832M, up 2% from $816M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw withdrew a net $29.5M in Q4 2015, closing 9 positions and reducing 130 holdings. Its most notable exit was HUBBELL INC CL-B, an estimated $3.24M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Energy.

Against the trend, Neville Rodie & Shaw opened a new position in Alphabet (Google) Class A worth $11.6M.

  • Neville Rodie & Shaw's largest Q4 2015 buy was Alphabet (Google) Class A: 298,500 shares worth $11.6M.
  • Neville Rodie & Shaw added most to Visa in Q4 2015, an estimated $4.52M increase.
  • Neville Rodie & Shaw's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $10.8M.
  • Neville Rodie & Shaw fully exited HUBBELL INC CL-B in Q4 2015, selling an estimated $3.24M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $832M portfolio in Q4 2015.
  • Neville Rodie & Shaw opened 12 new positions and closed 9 in Q4 2015.
  • Neville Rodie & Shaw's portfolio value rose 2% quarter-over-quarter to $832M.

Based on Neville Rodie & Shaw's 13F filing for Q4 2015, filed 22 Jan 2016.